Precision Medicine and its Role in the Treatment of Sepsis: A Personalised View
- PMID: 31431921
- PMCID: PMC6698074
- DOI: 10.2478/jccm-2019-0017
Precision Medicine and its Role in the Treatment of Sepsis: A Personalised View
Abstract
In recent years, a new form of medicine has become increasingly significant, namely, personalised medicine (PM). PM is a form of care in which treatment is tailored for an individual patient. PM is about using multiple data sets to create a digital human mapping. A person's biological traits are determined by the interactions of hundreds of genes and gene networks, as well as external factors such as diet and exercise. Combining and then investigating these multiple databases with powerful statistical tools, allows a new understanding of how genetic intricacy drives health and disease and so leads to a closer personalised medical approach that targets each individual's unique genetic make-up. Sepsis is a systemic inflammatory response to infection, ranging from systemic inflammatory response syndrome (SIRS) to septic shock and multiple organ dysfunction syndromes (MODS). Sepsis is the most common cause of death in intensive care patients. Treatments in an ICU may need to be adapted to the continuous and rapid changes of the disease, making it challenging to identify a single target. PM is thus seen as the future of sepsis treatment in the ICU. The fact that individual patients respond differently to treatment should be regarded as a starting point in the approach to providing treatment. The disease itself comes secondary to this concept.
Keywords: genome; intensive care; multiple datasets; precision medicine; sepsis.
Conflict of interest statement
Conflict of interest None to declare
Similar articles
-
Sepsis Care Pathway 2019.Qatar Med J. 2019 Nov 7;2019(2):4. doi: 10.5339/qmj.2019.qccc.4. eCollection 2019. Qatar Med J. 2019. PMID: 31763206 Free PMC article.
-
Epidemiology of sepsis and multiple organ dysfunction syndrome in children.Chest. 1996 Apr;109(4):1033-7. doi: 10.1378/chest.109.4.1033. Chest. 1996. PMID: 8635327
-
Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.Med J Aust. 2019 Nov;211 Suppl 9:S3-S46. doi: 10.5694/mja2.50383. Med J Aust. 2019. PMID: 31679171
-
The epidemiology of the systemic inflammatory response.Intensive Care Med. 2000;26 Suppl 1(Suppl 1):S64-74. doi: 10.1007/s001340051121. Intensive Care Med. 2000. PMID: 10786961 Free PMC article. Review.
-
Outcome of patients with sepsis and septic shock after ICU treatment.Langenbecks Arch Surg. 1998 Mar;383(1):44-8. doi: 10.1007/s004230050090. Langenbecks Arch Surg. 1998. PMID: 9627170 Review.
Cited by
-
Fluid Therapy from Friend to Foe.J Crit Care Med (Targu Mures). 2023 Jul 31;9(3):135-137. doi: 10.2478/jccm-2023-0019. eCollection 2023 Jul. J Crit Care Med (Targu Mures). 2023. PMID: 37588185 Free PMC article. No abstract available.
-
Personalized Physiological Medicine as the Future of Intensive Care Medicine.J Crit Care Med (Targu Mures). 2022 Aug 12;8(3):143-144. doi: 10.2478/jccm-2022-0020. eCollection 2022 Jul. J Crit Care Med (Targu Mures). 2022. PMID: 36062040 Free PMC article. No abstract available.
-
Unifying cardiovascular modelling with deep reinforcement learning for uncertainty aware control of sepsis treatment.PLOS Digit Health. 2022 Feb 17;1(2):e0000012. doi: 10.1371/journal.pdig.0000012. eCollection 2022 Feb. PLOS Digit Health. 2022. PMID: 36812511 Free PMC article.
-
Is Carboxyhaemoglobin an Effective Bedside Prognostic Tool for Sepsis and Septic Shock Patients?J Crit Care Med (Targu Mures). 2023 Nov 14;9(4):239-251. doi: 10.2478/jccm-2023-0031. eCollection 2023 Oct. J Crit Care Med (Targu Mures). 2023. PMID: 37969884 Free PMC article.
-
Development and Trends in Artificial Intelligence in Critical Care Medicine: A Bibliometric Analysis of Related Research over the Period of 2010-2021.J Pers Med. 2022 Dec 27;13(1):50. doi: 10.3390/jpm13010050. J Pers Med. 2022. PMID: 36675711 Free PMC article.
References
-
- Vea A, Llorente-Cortes V, de Gonzalo-Calvo D. Circular RNAs: a novel tool in cardiovascular biomarker development? Non-coding RNA Investig. 2018;2:39.
-
- Valpione S, Martinoli C, Fava P, Mocellin S, Campana LG, Quaglino P. Personalized medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumab. EJC. 2015;14:2086. –. - PubMed
-
- Molinaro S, Pieroni S, Mariani F, Liebman M. Personalized medicine: Moving from correlation to causality in breast cancer. European Journal of Molecular & Clinical Medicine. 2015;2(2):59.
Publication types
LinkOut - more resources
Full Text Sources